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Abstract
Access to medical care and health screenings is a necessity for patients around the
globe, but it can be difficult to provide this without screenings becoming costly or convoluted.
In rural and underdeveloped areas, patients are often disadvantaged when it comes to finding
reliable and affordable healthcare. The isolation provided by their location and the rising costs
of physicians makes it impossible for most impoverished communities to attain personalized
care. Because of this, treatable diseases often go unaddressed, allowing diseases to progress to
a critical condition. Mortality rates have shown to be higher in communities located in rural
areas and among destitute economies. Telemedicine is one solution to improve rural health
care by allowing patients to have remote access to health services. Our goal for this project
would be to provide simple and fast diagnosis to detect urine albumin levels, urobilinogen,
nitrite, as well as pH and glucose levels combined with telemedicine to provide reliable results.
Thus far, we have completed tests for the previously mentioned parameters and have
reached out to the World Health Partners in order to propose collaboration on the project. We
have also reached out to the Computer Engineering team in order to normalize the images
captured by the diagnostic device. Once the project reaches its conclusion, we believe that the
introduction of this device into rural areas would effectively monitor patient health as well as
improve the overall quality of life for those in impoverished conditions.
Key words: urinalysis, medical, mobile screening, health monitoring, mobile web
application, rural, low-income, preventative medical care, telemedicine, developing world
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1

Introduction

1.1

Problem

Impoverished Communities Lack Access to Health Screening
Routine checkups allow physicians to monitor a patient’s health and alert them to any
potential issues that could indicate a disease. Routine health screenings allow diseases to be
diagnosed in their early stages, giving patients the ability to seek treatment and prevent
diseases from reaching a life-threatening condition.1 However, patients in rural areas face
certain barriers that prevent them from getting screened regularly. Patients in rural areas
require access to transportation in order to reach health services as well as a means to pay for
the services.2 Because of these barriers, patients in rural areas will instead skip health
screenings entirely, allowing diseases like diabetes and coronary heart disease to go untreated
and reach critical conditions.3 Lack of doctors and other medical professionals is also an issue
in rural health care services. In order to have reliable health care for patients living in rural
areas, it is important to have trained clinicians who can adeptly handle lab equipment and
provide patients with trustworthy healthcare.4

1.2

Existing Solutions

Urinalysis Test Strips

9Health Fair. “Health Screening.” 9Health Fair: Health Screening, Colorado School of Public Health,
9healthfair.publichealthpractice.org/module4/1_index.htm.
2
Rural Health Information Hub. “Rural Health Information Hub.” Healthcare Access in Rural Communities
Introduction, Rural Health Information Hub, 9 June 2017, www.ruralhealthinfo.org/topics/healthcare-access.
3
National Rural Health Association. “NRHA.” NRHA, National Rural Health Association, National Rural Health
Association, 2016, www.ruralhealthweb.org/about-nrha/about-rural-health-care#_ftn1.
4
Warshaw, Robin. “Health Disparities Affect Millions in Rural U.S. Communities.” AAMCNews, Association of
American Medical Colleges, 30 Oct. 2017,
news.aamc.org/patient-care/article/health-disparities-affect-millions-rural-us-commun/.
1
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Urinalysis tests are one possible solution to the improving the health of patients in rural
communities. Urinalysis tests allow patients to monitor their health easily at home and can alert
them when the concentration of analytes predictive of health complications fall outside of their
healthy physiological ranges. Urinalysis tests can be used to rapidly detect high urine glucose,
nitrite, urobilinogen, albumin, and other urine analytes that can be indicative of health risks
during pregnancy.5 These tests are also easily accessible and can be purchased at the pharmacy
or over the internet without the need of a prescription. While urinalysis test strips can be used
to detect health abnormalities through the detection of biological markers, they are not meant
to be used for self-diagnosis.6 Additionally, users should follow up urinalysis results with a
checkup by a medical professional. The most commonly reported issues with urinalysis strips
are that their results are not easily readable and that the instructions do not warn or inform
patients how to avoid chemical contamination. These two factors need to be considered when
interpreting urinalysis test results and when designing improved urinalysis tests.
Clinical Screening Services
Clinical screening services available in rural poor areas are a viable option for patients,
however, they can become costly for those that need to schedule regular checkups. Clinical
screening services also run the risk of human error because tests are analyzed by clinicians.7
Thirdly, the screenings made available by these services may not be useful to those with
non-technical backgrounds if translations of the results depends upon medical professionals.
CLINITEK Advantus Urine Chemistry Analyzer
The CLINITEK Advantus Urine Chemistry Analyzer is available for purchase and is
able to evaluate over 500 tests/hour.8 However, this device is not a practical option for patients

“Urine Test: Urinalysis.” American Pregnancy Association, 2 Sept. 2016,
americanpregnancy.org/prenatal-testing/urine-test/.
6
“Urinalysis.” Lab Tests Online: Empower Your Health. Understand Your Tests. A Public Resource on Clinical
Laboratory Testing., May 2016, labtestsonline.org/understanding/analytes/urinalysis/tab/test/.
7
Naylor, C.d. “Grey Zones of Clinical Practice: Some Limits to Evidence-Based Medicine.” The Lancet, vol.
345, no. 8953, 1995, pp. 840–842., doi:10.1016/s0140-6736(95)92969-x.
8
“Home.” CLINITEK Advantus Analyzer - Siemens Healthineers USA, 2017,
usa.healthcare.siemens.com/point-of-care/urinalysis/clinitek-advantus-urine-chemistry-analyzer.
5
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in rural poor areas. The device itself is bulky, making mobilization infeasible. The cost of the
device (roughly $8,000) is also out of the range of the target audience.
Educational SMS Messages
Mobile phones make it possible to easily educate individuals in low- and
middle-income communities about their health. Health education and resources can be shared
rapidly with the patient via SMS messages.9 Unfortunately SMS messages are limited to
preventative care and health education rather than reactionary emergency care.
Mobile Clinics
Mobile clinics are able to provide healthcare services to individuals who are typically
unable to access healthcare due to travel distance.10 However, mobile health clinics are not
efficient because they lack resources and often do not have accurate screening technologies.
Smartphone-Based Colorimetry
Smartphone apps with access to a camera are able to digitize colors of a colorimetric
sensor array and evaluate color changes in biological samples that may otherwise be
undetectable to the naked eye.11 While smartphone-based colorimetry may be valuable in
evaluating biomarkers detected in urinalysis tests, one of the major disadvantages of
smartphone cameras is that they are vulnerable to changes in ambient light.12 In order to
eliminate analysis errors that may appear because of inconsistent lighting, a case must be made
to hold the device and the strips that need to be analyzed in order to obtain the most accurate
results for diagnosis.

1.3

Proposed Solution

9

Lamont, Kim, et al. “Short Message Service (SMS) as an Educational Tool during Pregnancy: A Literature
Review.” Health Education Journal, vol. 75, no. 5, 2016, pp. 540–552., doi:10.1177/0017896915607910.
10
Vavasis, Anthony. Mobile Health Clinics in the United States . 2013, pp. 1–36, Mobile Health Clinics in the
United States .
11
Hong, Jong Il, and Byoung-Yong Chang. “Development of the Smartphone-Based Colorimetry for
Multi-Analyte Sensing Arrays.” Lab Chip, vol. 14, no. 10, 2014, pp. 1725–1732., doi:10.1039/c3lc51451j.

Kim, Seung Deuk, et al. “A Smartphone-Based Automatic Measurement Method for Colorimetric PH Detection Using a
Color Adaptation Algorithm.” Sensors, vol. 7, no. 17, 10 July 2017, pp. 1–13., doi:10.3390/s17071604.
12
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Urinalysis Screening for Rural Communities
Urinalysis Screening for Rural Communities (USRC) project uses urine strip tests to
perform health screenings for patients and and communicates results via a mobile application.
USRC aims to give people in poor rural communities access to health screenings that are easily
understood so that those with non-technical backgrounds may interpret results from urinalysis.
The web application will calculate results from a urine test strip after an image of the strip is
captured by an external imaging device. By mapping the colors captured from the tested strips
to their respective concentrations, the results will be translated into statistical data that will
make it easy for the user to understand their test results. The information will also be accessible
to medical professionals and/or licensed technicians who will then be able to give a patient a
formal diagnosis and treatment if needed. The application will also be able to map the medical
history of patients in order to deliver the most well informed care. The current USRC initiative
will build upon the progress of an iteration of the MUMS project from two years ago, which
was able to successfully perform urinalysis tests for hemoglobin and glucose monitoring for
maternal screening to improve detection of pregnancy complications and increase the
probability of successful.
We will expand upon the previous group’s accomplishments by adding parameters to
extend the range of analytes detected by the device during urinalysis and target a wider
demographic instead of just maternal patients. We would like our web application to be able to
accurately detect the levels of analytes in urine being examined and return data that will be
easy for the user to understand. When patients are able to monitor their health regularly from a
remote location, complications associated with pregnancy may be detected more feasibly.
Feasible detection of health complications may allow for patients to detect diseases earlier on
and be able to monitor their health more frequently over time. Additionally, early detection
will notify patients to seek further medical treatment if necessary.

1.4

Objectives

Reduce Mortality Rate of General Patients, Infants, and Mothers

11

The primary objective of the USRC project is to notify patients of potential risks to
their individual health that may lead to death, or other serious complications that could easily
be avoided by general screenings. The USRC project hopes to provide a device to detect
diseases early on so that mothers will be informed if they are at risk for complications.
Thereby, USRC will improve the prevention of both miscarriages and maternal death.
Improve General Health
Another objective of the USRC project is to improve the health of patients living in
rural areas. The proposed device will be able to monitor the specified parameters of the patient
in order to detect disease early on and prevent life-threatening conditions. The web application
should also be able to store patient history so that patients and/or clinicians may be able to
identify changes in the patient’s health.
Enhance Patient Database
The web application should be able to store information regarding the patient’s past
urinalysis results, as previously mentioned. We hope to add further parameters for testing to
the database from the previous MUMS project. Additionally, part of this objective is to create a
patient database that is secure and keeps patient information confidential.
Calibrate Urine Test Strips Accurately
The web application must correctly map the colors displayed on the urine test strips to
the corresponding concentrations of different parameters. The calibration algorithm must be
able to translate the captured images of test strips into proper diagnoses. This will be achieved
after distinguishing the spectrum of possible colors on the test strips, and mapping them to
correct diagnoses based on the concentration on that particular strip.
Design a Frugal and Efficient Screening Device
The device created must be frugal and efficient in order to be accessible and reliable to
our target users. When designing our device we will need to consider the materials used and
portability of the device so that it can be both frugal and effective. Furthermore, we will aim to
maximize the reusability of our device so that patients in poor rural communities are not
12

burdened by the cost of frequently purchasing new devices. The device will also need to be
easily calibrated so that results are accurate and can be used to inform diagnosis.

1.5

Expected Results
We believe that our design will improve the lives of patients living in rural areas. Our

device’s adoption would lead to an influx of test results and patient data on our database. We
also expect that there will be a decrease in the frequency of lengthy trips to mobile clinics
made by patients. Our device will also reduce current redundancies in how biomarkers are
measured in urine. It will also be able to accommodate other strips and be able to test for a
variety of parameters: urobilinogen, urine albumin, glucose, pH, nitrite, and hCG. The levels of
these parameters are often indicative of greater health problems that need constant monitoring.
Long term use of our device may be expected to increase in the number of patients in
rural areas diagnosed with diabetes, kidney failure, or other general health issues, as fewer of
these complications would go unreported. Our device will also lead to an decrease in
misdiagnosis and unnecessary treatments that can be caused by inaccurate tests and readings.

1.6

Impact

Economic Impact It is imperative that we consider market forces as we design and implement
our device. Our device must be an improvement over existing solutions otherwise it will
become an obsolete product that will only be costly to taxpayers and governments.
Health and Safety The device must be accurate in determining the test results in order to
prevent false positives or negatives that would confound the administration of healthcare to the
patient. It must be accurate enough that the users of the device are confident in the data the
device returns to them after a urinalysis test. A misdiagnosis from this device may lead to the
patient pursuing costly treatment he or she does not need or not receiving treatment that they
desperately need for themselves. Additionally, we must ensure that our device can be easily
cleaned and has a mechanism to easily dispose of used urine strips. It is our primary concern
that our device is a means of promoting health and wellness, not a means of spreading disease.

13

Sustainability The material of our device must be inexpensive and sustainable. We do not want
to use materials that are harmful to our environment or to the environment of our target
customer. The production to fabricate the materials we use must be minimally harmful to the
environment, if at all. Furthermore, our device must be durable so that it is reusable and use of
materials for production is minimal. Lastly, the disposal of strips and urine must be clearly
defined for users so they do not release any harmful toxins into the environment.
Manufacturability The manufacturing of our device must be efficient and low cost so that we
are able to produce a device that is accessible to the target audience.
Environmental Our project aims to provide patients living in rural poor communities with
convenient and local means of medical screening. Therefore our device will likely reduce the
distance that inhabitants of rural communities need to travel to seek medical testing. This may
lower carbon emissions produced by vehicles otherwise used by these patients to travel to and
from unnecessary medical appointments.
Ethical It is imperative that our project improve and not hinder healthcare. However, our
device must be produced and implemented in an ethical manner. Our materials must be sourced
from companies that follow good manufacturing practice (GMP) and do not harm the
environment or other living beings. Our device must also be implemented in a manner that
considers the sensitive nature of both the information the device collects as well as provides.
Care must be taken to ensure that information reported is accurate and information collected is
stored securely so that our device does not endanger the health or privacy of the patients it
seeks to serve. Special care will be taken to ensure that the web-based portion of our device is
secure from potentially compromising attacks.
Political Our web application will use an online database to store the medical information of
patients using our device. Care will be taken to ensure that our platform and device do not
violate any laws that regulate the collection of sensitive healthcare data, such as the Health
Insurance Portability and Accountability Act (HIPAA). It is important that the database for the
patients is only accessible to healthcare workers and/or patients and cannot be seen by others.

14

Social We must be aware and respectful of our target customers’ culture. It is essential that our
device abides by the cultural expectations of our target customers and does not harm or offend
the patients that it seeks to serve. We hope to minimize this possibility by partnering with the
World Health Organization.
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Project Management

2.1

Team Management

Bioengineering Team
The bioengineering team is advised by Dr. Unyoung Kim. The bioengineering team
will test six different parameters that the device will be able to detect. The biological markers
being tested are: nitrite, urobilinogen, urine albumin, glucose, pH, and hCG. Four of the six
parameters being tested - nitrite, urobilinogen, glucose, and pH - are being tested by using
Siemens 10 SG Reagent Strips while hCG is to be tested with Wondfo Pregnancy Strips. The
last parameter, urine albumin, is to be tested using a strip made by our team.
The bioengineering group will also be responsible for creating the device that the strips
will be analyzed in. This device is intended to prevent contamination of the strips that could
result in false positives or negatives for the user. In order for the device to be feasible for use in
rural communities, it should be designed with an external imaging device that is available in
such communities, such as a tablet.
Primary Computer Engineering Team
The primary computer engineering team is advised by Dr. Silvia Figuera. The primary
computer engineering team will be responsible for calibrating the data that the bioengineering
team obtains from the urinalysis tests so that the mobile web application can determine when
abnormalities in the urine are present. The computer engineering team will implement image
analysis so that our device is able to predict biomarker concentrations from the images taken of
the strips. With the biomarker concentrations the computer engineering team will then design
an algorithm that is able to suggest the proper diagnoses so the user knows what steps to take
to maintain their health.
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Secondary Computer Engineering Team
The secondary computer engineering team is also being advised by Dr. Silvia Figuera
and will primarily be working on the web application. They will be responsible for designing a
web application that is capable of tracking longitudinal patient data and can use these patient
history data to provide statistical recommendations to the user. The data will be stored in a
patient database which should be secure and only accessible to the user conducting the
urinalysis tests with the device. The web page for the app should be easy to use so that the user
can access the necessary information without any complications.

2.2

Back-up Plan
Should the device fail, we have a backup plan to rectify the situation. Our protocol calls

for us to design a separate strip, divorced from the other strips that are available through the
market. Should the device fail, we could combine both siemens and the pregnancy test with the
urine albumin test into a singular strip. Rural areas could be supplied with this singular strip
and given a biomarker concentration color chart to monitor their health for themselves. The
previous group’s device could still be marketed in the scenario that we are not able to make a
marked improvement on their design, thus allowing patients to still be able to attain a
somewhat accurate reading. This would not be ideal, but if it were the case then we would need
to communicate the change with the primary and secondary computer engineering team in
order to provide them with the necessary results.

2.3

Budget
The budget for our prototype is $1475. The majority of our funding was utilized to

purchase chemical reagents to test and calibrate urinalysis strips. The cost of chemical reagents
will not burden potential users of the device because they will be using either their own urine
or a patient’s urine. The bulk of the cost for consumers and patients will come from imaging
equipment. However, we do not feel that the cost of imaging equipment is enough to disclude
the device from being accessible and affordable because the equipment can be purchased for a
one time fee and is reusable. The device casing will similarly be purchased for a one time fee
and be reusable. The only component of our device that will be a recurring cost for patients
16

and/or caregivers will be the cost for a set of urinalysis strips. However, the cost for urinalysis
strips is minimal and more affordable than other methods of diagnostic testing. In Table 2.3-1
the costs for both the prototype and estimation of a single device can be found.
Table 2.3-1 Prototype and Estimated Production Cost Componential Breakdown
Item

Vendor

Number of Item

Prototype Cost

Estimated
Production
Cost

Siemens Multistix 10 SG
Reagent Strips (100
count)

Siemens

2

$111.06

$0.55/strip

Wondfo Pregnancy Strips
(25 count)

Wondfo

1

$9.59

$0.19/strip

Cynmar Urine Test Strips
- glucose, pH, protein,
ketones (50 count)

Cynmar

1

$25.13

$0.50/strip

Human Serum Albumin
(50mg)

Sigma Aldrich

1

$173.00

0

Thiazole Yellow G (5g)

Sigma Aldrich

1

$11.40

$2.28

Bromophenol Blue (25g)

Sigma Aldrich

1

$81.00

$3.25

Citric Acid

Santa Clara
University

1

$42.00

$0

Whatman Filter Paper

Sigma Aldrich

1

$36.70

$0.37/paper

0.010”x21”x51” Clear
Rigid Vinyl Sheet

United States
Plastic Corp.

5

$5.67

$1.13

Urobilinogen (mg)

Lee
Biosolutions

1

$79.00

$0

hCG

Sigma Aldrich

1

$63.00

$0

Sodium Nitrite

Sigma Aldrich

1

$45.90

$0

Glucose

Santa Clara
University

1

$0

$0

NaOH

Santa Clara
University

1

$0

$0
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HCl

Santa Clara
University

1

$0

$0

Samsung Galaxy Tab A

Amazon

1

$107

$107

Table 2.3-2 Prototype and Estimated Production Cost of Albumin Strips
Item

Vendor

Number
Item

Prototype Cost

Estimated
Production
Cost

Thiazole Yellow (5g)

Sigma Aldrich

1

$11.40

$2.28

Bromophenol Blue
(25g)

Sigma Aldrich

1

$81.00

$3.25

Whatman Filter Paper

Sigma Aldrich

1

$36.70

$0

Citric Acid

Santa Clara
University

1

$0

$0.37

Clear Rigid Vinyl Sheet

United States
Plastic Corp.

5

$5.67

$1.13

$176.77

$0.29 per strip

Total:

2.4

Timeline
Our schedule for the Fall quarter of our senior year has been accomplished for the most

part. Our objectives for this time period was to finalize our design proposal and order materials
for the testing process. We also sought to conduct a glucose test to establish a baseline similar
to that of the previous group.
Winter Quarter, we are hoping to complete numerous tests and produce results that
could be communicated with computer engineering groups. We also need to build the device
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that will be capturing the data, improving on the previous groups design in doing so. We would
also need to analyze the data to ensure it is accurate enough for the patient database.
Spring Quarter will involve the finalizing of our project. We will be finishing the
testing and data collection stage of our design. We will also complete the presentation portion
of our senior design project as well as our thesis. This quarter will be reserved for any last
minute troubleshooting that may need to occur when working in correspondence with the
Computer Engineering teams.
A further breakdown of our design process can be found in Table 2.4-1
Table 2.4-1 Year Long Design Process Timeline

Fall Quarter

Winter Quarter

Spring Quarter

Research

Conduct Tests

Final Testing

Develop Protocol

Build Prototype

Finalize Design

Design Device

Test Device

Begin Tests

2.5

Design Risks
Table 2.5-1 shows the risks that we may encounter with our project. Each risk listed is

followed by an expected consequence, the probability of the risk, its severity, its impact, as
well as a prevention measure against the possible risk. The severity of the risk is ranked on a
scale of 1-10 and the impact is the product of the corresponding probability and severity.
Table 2.5-1: Potential Risks That May Be Faced During Product Development
Risk

Consequence

Probability Severity

Impact

File Loss

Loss of work
in progress

0.4

3.2

6

19

Mitigation Strategies
1. Backup files in
separate hard drive
2. Utilize version
control such as
Github

Insufficient
Development
Knowledge

The system
will not
include the
features as
described

0.3

7

2.1

1. Seek help from
online tutorials
2. Find an alternative
approach

Illness

Team
member(s)
will be unable
to work on
the project

0.2

4

0.8

1. Keep up good health
practices

Exposure to
Dangerous
Chemicals

Life
threatening
chemicals can
affect health
of team
member(s)

0.3

8

2.4

1. Practice proper lab
protocols and
handling of lab
equipment and
chemicals
2. Be familiar with EHS
guidelines

3

System Design

3.1

System Level Overview and Analysis

Protocols
Several protocols were written in order to test for the necessary biomarkers of the the
project. These protocols involved the glucose testing, pH testing, urinalysis for nitrite,
urinalysis for urobilinogen, hCG testing, and urinalysis for albumin.
Urinalysis for glucose was taken by taking a the powder form of glucose and mixing it
with deionized water in order to create a stock solution. This stock solution was then used in
order to create buffer solutions of 2000 mg/dL, 1000 mg/dL, 500 mg/dL, 200 mg/dL, 160
mg/dL, 130 mg/dL, 100 mg/dL, and 60 mg/dL. The strips were placed into the solution.
Results were visible after 30 seconds and could be captured by the imaging device.
Testing for pH involved the use of HCl as well as NaOH and deionized H2O. Buffer
solutions with ranging from pH of 5 to a pH of 11 were created using the three above stated
chemicals. A pH meter was used to verify the ranges in pH and the siemens strips were then
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dipped into the buffer solutions. Results were then visible after 60 seconds and could be
captured by the imaging device.
Nitrite levels were tested through the use varying nitrite solution and deionized water.
Ratios were taken of the stock and nitrite until 0.08 mg/dl, 0.06 mg/dl, 0.05 mg/dl, 0.025 mg/dl
dilution were made. The dilutions were then tested via the Siemens strips. Results were then
visible after 60 seconds and could be captured by the imaging device.
Analysis of urobilinogen required us to create a stock solution of 8 mg/dL using 0.08 g
of urobilinogen and 1 liter of deionized water. Serial dilutions of 8 mg/dL, 4 mg/dL, 2 mg/dL,
1 mg/dL, 0.2 mg/dL were made and then tested with the Siemens strips. Results were then
visible after 60 seconds and could be captured by the imaging device.
Analysis of albumin required the creation of an entirely new urinalysis strip. In order to
accomplish this task we used the chemicals bromophenol blue, thiazole yellow, and citrate
buffer. Mixing these three chemicals together created a homogenous chromogen solution
which we then immobilized onto filter paper. Once immobilized, the filter paper was adhered
to a plastic sheet and cut into manageable strips. A stock solution of human albumin was then
taken and diluted into dilutions of 1000, 300, 100, 30, and 10 mg/dL. The strips were placed
into the solutions and allowed to sit for twenty seconds before being imaged by the device.
Pregnancy analysis required us to reconstitute lyophilized hCG to generate stock hCG
solution at a concentration of 1,000 IU/ml. This stock solution was then used to generate a
6,400 mIU/ml solution which was then diluted to 3200 mIU/ml, 1600 mIU/ml, 800 mIU/ml,
400 mIU/ml, 200 mIU/ml, 100 mIU/ml, 50 mIU/ml, 25 mIU/ml, 12.5 mIU/ml, 6.25 mIU/ml,
3.12 mIU/ml, and 1.56 mIU/ml samples by a performing a series of serial dilutions. Results
were then visible after 5 minutes and could be captured by the imaging device. Because
Siemens strips lacked the capabilities to test for pregnancy, we instead used Wondfo strips.

3.2

Hardware
We have designed an imaging unit to be used in order to accurately evaluate

biomarkers of chronic kidney disease. It was made from ¼” and ⅛” opaque acrylic in order to
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reduce reflected light.13 However there were a few issues that we encountered while using this
device. The initial design, which we have improved upon, consists of a single cover, a test strip
slide, tablet support arms, as well as a main body. For instance, the top of the tablet was
designed in such a way as to only support iPad 4’s as the primary image capturing device
because of its availability and ease of use in the United States. The slide deck that would
normally house the test strips is also built with only siemens multistix in mind. The test strip
slide is constructed from acrylic and tape which prevents the LED lights of the device from
reflecting excess light into the camera, however, this also lends itself to ease of use issues. The
tape would often catch on the inside of the device preventing users from sliding the strip into
the imaging compartment. There is also a gap between the strip and the bottom of the slide that
causes positioning error when imaging the strip. Ideally, our final design will be able to
eliminate the excess lighting as well as position the urinalysis strips consistently.

Figure 3.1-1 Top view of urinalysis device
Our main unit features a lithium battery that will be rechargeable. The main unit also
houses the LED switch that controls the function of the LED lights.

13

Neumeyer, Joseph, et al. “Mobile Urinalysis for Maternal Screening: Frugal Medical Screening Solution and
Patient Database to Aid in Prenatal Healthcare for Expecting Mothers in the Developing World.” 2016 IEEE
Global Humanitarian Technology Conference (GHTC), 2016, doi:10.1109/ghtc.2016.7857337.
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We have made the top casing to be interchangeable with multiple iterations so as to
accommodate different tablets available to our partners in India. Removing and replacing the
top casings could also be improved upon for ease of use.
The tablet support arms that acted as structural support for the original design are
absent from our device in order to improve ease of use. After receiving feedback from our
contact in WHP, we determined that the support arms were unnecessary for the smaller tablets
available to them. As a result, the main unit is slightly wider in design as well as shorter in
length in order to maintain stability when the imaging unit is mounted in place.
We have constructed multiple slide decks in order to accommodate the different sizes in
test strips as well as improved the tape coating. Positioning the strip is no longer an issue and
excess liquid does not remain contained in the crevice of the slide decks, making the
disinfection process much easier. This is due in part to the design decision to switch the scotch
tape of the original design with electrical tape.

3.3

Customer Needs
Our client, World Health Partners, is located in India. World Health Partners (WHP) is

a non-profit organization that provides healthcare to underserved communities. When
designing our device we have had to keep in mind the resources available to the communities
that WHP works with. During our design review process, our client informed us that the tablets
available in India are different than the tablets available in the United States. We therefore,
have had to modify part of our hardware to accommodate different tablets. In particular, the
position of the camera lens varies between tablets. We have factored this difference into our
final design.
Similar to our modifications to suit the client’s tablet, we have also had to consider the
urinalysis strips commercially available in India. Amidst our design process, our client shared
with us what the common urinalysis strips used are. The strips used in India detect for the same
parameters that our team has been testing for. Therefore, our parameters are compatible with
the parameters that the client desires to be diagnosed.
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Other considerations that our client has shared with us are regarding the hardware
component of our device. As aforementioned, our device prototype has dimensions of 29 cm x
8.1 cm x 12.9 cm and weighs 3.2 lbs. Upon review, our client informed us that the dimensions
and weight suit the needs of their organization. However, they suggested we modify our power
source and use lithium batteries instead of a power cord. Another hardware consideration was
the strip holder. Our client asked that the strip holder be able to accommodate a variety of
potential urinalysis strips.

3.4

Software
The design includes the tablet being linked to a mobile application that will be able to

analyze the images taken by the tablet and device in order to diagnose patients for various
health risks and/or diseases. In order for the application to properly analyze test strips of
unknown concentrations, it would require calibration. The activity diagram in figure 3.1-2
guides users along the calibration process.

Figure 3.1-2 Activity diagram for users of the mobile application

The calibration process starts with the user selecting a biomarker and testing it specific
concentrations. Using the tablet and casing, the user will then have to take a picture of the test
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strip and continue testing the biomarker until a wide range of concentrations have been tested.
Once images have been taken for each of the concentrations, they would each be cropped in
order to isolate the reagent pad of the biomarker being tested. These cropped images would be
uploaded onto Matlab, which would then run our image analysis algorithm. This algorithm
analyzes each image and captures the red, green, and blue intensity values of each
concentration. It then obtains the average of these values plots them onto a graph. These graphs
were created in order to normalize the images captured by the strips and compared to the
theoretical values proposed by the Siemens strips. The polynomial equations that make up the
graph are the same equations that the mobile application will use in their image analysis
algorithm to test for unknown concentrations. This process is repeated for each of the desired
biomarkers.

4

Protocols

4.1

Urinalysis for Glucose

Procedure
Clinically acceptable levels of glucose in urine is usually less than 130 mg/dL.14
Knowing this, we created several solutions that were made to simulate glucose in urine ranging
from 0 mg/dL to 2000 mg/dL. Higher concentrations were used in order to better understand
the limitations of the reagent test strips.
Both the Cynmar test strips as well as the Siemens Multistix were then dipped into the
solutions for 60 seconds in order to attain an accurate concentration. The strips were then
placed into the prototype device and photographed to record the corresponding color to the
concentration. Each dilution was tested and then imaged using the device.

4.2

Urinalysis for pH Test

Procedure
In order to test the pH ranges of the strips, we created buffer solutions using deionized
water as well as HCl and NaOH. A pH meter was also employed in order to validate the buffer
solutions that we created for testing. The Siemens Multistix 10 SG reagent strips were expected

14

“Understanding Urine Tests.” National Center for Biotechnology Information, U.S. National Library of
Medicine, 30 Dec. 2016, www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072534/.
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to be able to detect a range of pH in urine starting from a pH of 5 and ending at pH of 9,
dependent on acid-base status of patient as well as diet.15 However, our team decided to use
buffer solutions ranging from a pH 5 to a pH of 11 due to the sensitivity of the Siemens
Multistix. While changes in color were meant to be detected by pH 7, real changes in color
were not seen until after a pH of 9, so we performed tests above the range given on the
Siemens Multistix package. Three reagent strips were placed in their corresponding pH
solutions and then placed in the device for imaging. A total of thirty seconds was allowed for
the color to fully develop before imaging the strip.

4.3

Urinalysis for Nitrite

Procedure
A solution with a pH of 6.0 was made for the experiment by measuring out 10 mL of 1
M KH2PO4 and combining it with 90 mL of DI H2O as well as 11.2 mL of 0.1 M NaOH. The
resulting reaction produced is 0.05 M of KNa2PO4
In order to generate samples containing nitrite, one milligram of sodium nitrite (ACS
reagent, ≥97.0%) was dissolved into 10 dL in order to generate 0.1 mg/dL of sodium nitrite
solution. From this solution we made a series of dilutions from 0.08 mg/dL, 0.06 mg/dL, 0.05
mg/dL, 0.025 mg/dl. We dipped the Siemens test strips into the dilutions and waited 60
seconds for the results to appear. Each dilution was tested and then imaged using the device.
There is no acceptable range of nitrite in urine, thus the range of dilutions was miniscule.14

4.4

Urinalysis for Urobilinogen

Procedure
To perform the urinalysis tests for urobilinogen, we first created a stock solution of 8
mg/dL for urobilinogen in water. The stock solution would then be diluted down with DI water
to test for different concentrations and tested using the siemens multistix 10 SG reagent strips.
A stock solution of 8 mg/dL of urobilinogen in water was created for the urobilinogen
tests and diluted down. The acceptable amount of urobilinogen in urine was found to be 0.5-1

“Understanding Urine Tests.” National Center for Biotechnology Information, U.S. National Library of
Medicine, 30 Dec. 2016, www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072534/.
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mg/dL.16 As a result, we decided to test for urobilinogen concentrations between 0 - 8 mg/dL.
The higher concentrations were also included in our testing because those levels of
urobilinogen could be detected using the urinalysis strips that were being used to test for
urobilinogen.
To test for urobilinogen, the Multistix test strip was dipped into the solution and dried
of excess fluid. A photo of the result was taken after sixty seconds. Observations of these
results were recorded and analyzed using the key provided with the Siemens Multistix 10 SG
Reagent Strips.17 Each concentration was tested three times following these same procedures.

4.5

Urinalysis For hCG

Procedure
To create a stock solution of hCG, we reconstituted lyophilized hCG in DI water. This
provided us with a stock hCG solution at a concentration of 1,000 IU/ml. To test for pregnancy
we prepared samples to generate concentrations ranging from 1.56 mIU/ml to 6400 mIU/ml.
We specified this range because 25 mIU/ml to 6400 mIU/ml indicates different stages of
pregnancy, but we wanted to test the sensitivity of the strips.18
Following the generation of dilutions, we dipped three Wondfo strips into each
concentration for 8 seconds. The 8 seconds allows for the test strips to fully absorb the solution
and display either a positive or negative result. After being dipped in the solution, the test strips
displayed results after 5 minutes and were then imaged.

4.6

Urinalysis for Albumin

Procedure
Due to the lack of test strips commercially available for urine albumin testing, we
decided to create our own strips using Bromophenol blue, thiazole yellow, and citric acid.
Bromophenol Blue and thiazole yellow (1mg/ml each) were prepared separately in 0.1M citrate
buffer (pH 2.49). We used 3.8497g of Citric acid and 5.8971g of trisodium citrate dihydrate in
order to create the citrate buffer needed in this experiment. We then mixed 130 ul of

“Understanding Urine Tests.” National Center for Biotechnology Information, U.S. National Library of
Medicine, 30 Dec. 2016, www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072534/.
17
www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/2/g5400pis.pdf+.
18
“HCG Levels.” Pregnancy Birth and Baby, Jan. 2017, www.pregnancybirthbaby.org.au/hcg-levels.
16
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Bromophenol blue and 40 ul of thiazole yellow with 0.9mL of 0.1M citrate buffer to get a
homogenous chromogen solution. Stock solution of human serum albumin (2000 mg/dL) was
then diluted with deionized water in order to prepare solutions of 1000, 300, 100, 30, and 10
mg/dL.
Similarly, different dilutions of albumin should also be made in urine if it is viable.
Unfortunately, we were not able to make urine dilutions, but this could be an improvement that
future groups can strive towards. The chromogen solution was immobilized on filter paper and
dried at 30oC for one hour in humidity free chamber for 1 hour. After immobilization and
drying, the filter paper was then pasted to a sheet of polystyrene plastic and cut into 5 mm wide
pieces that were 9.0 cm x 9.0 cm. The sheets of plastic were then dried in humidity free
chamber for two hours and then cut into 0.3 cm x 9.0 cm pieces in such a manner that one end
of the strip has the reagent pad and one end is free to handle. Strips should then be stored at
room temp. in brown bottles containing silica gel bags as desiccant. Tests using the different
dilutions of urine albumin can then be tested with the different concentrations of albumin.19 For
each test, the strips were dipped in the sample and an image was taken of the strip after twenty
seconds.

5

Results

5.1

RGB Graphs
RGB graphs for each parameter were created for each parameter: glucose, pH, nitrite,

urobilinogen, hCG, and albumin. Both glucose and pH have two graphs, one for the Siemens
Multistix and one for the Precision Strips used by WHP. These graphs were constructed using
MATLAB. To analyze the photos, the strip was cropped manually and evaluated using
MATLAB functions to determine the intensity of the red, green, and blue of the cropped
image. Depending on the concentration, the color of the strip would change accordingly. The
average RGB value of all of the samples for certain concentration were found and plotted with
the RGB intensity on the y-axis and the concentration of the biomarker being tested on the
x-axis. An RGB graph was constructed for all of the six biomarkers that were tested. The curve
Sharma, Sandeep K, et al. “Albumin Test Strip for Quick Detection of Albuminuria in Human.”Indian Journal
of Chemical Technology, vol. 9, Nov. 2002, pp. 496–498.,
nopr.niscair.res.in/bitstream/123456789/18915/1/IJCT%209%286%29%20496-498.pdf.
19
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fitting function on MATLAB was used to find the equations that would later be used for
calibration.

Figure 5.1-1: RGB Graph for Glucose for Siemens Multistix
Glucose was primarily tested from concentrations of 0-250 mg/dL. This is because the
clinically acceptable range of glucose in a patient’s urine is 130 mg/dL.20 However, the
concentration can be 180 mg/dL or higher depending on a patient’s condition like in Type 1
and Type 2 diabetes.21 Tests were also conducted beyond 250 mg/dL depending on the
detection ability of the strips.

20

“Understanding Urine Tests.” National Center for Biotechnology Information, U.S. National Library of
Medicine, 30 Dec. 2016, www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072534/.
21
IQWiG. “Type 1 Diabetes: Measuring Sugar Levels in Blood and Urine Yourself.” Advances in Pediatrics.,
U.S. National Library of Medicine, 29 June 2017, www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072521/.
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Figure 5.1-1 shows the RGB graph that was obtained for glucose. The graph depicts the
changing intensity of the red, green, and blue on the Siemens Multistix 10 SG Reagent strips as
the concentration of glucose increased. The strips were tested for concentrations of glucose
ranging from 0-2000 mg/dL because that was the capability of detection given on the Siemens
Multistix package. Based on the graph, the RGB values obtained can be used to predict the
concentrations below 1000 mg/dL. This makes it possible for the app to alert patients of
increasing glucose levels and allows clinicians to advise patients to seek treatment.

Figure 5.1-2: RGB Graph for Glucose for Precision Strips
Figure 5.1-2 above shows the RGB graph obtained for the glucose tests using the
Precision Strips used by WHP. The strips were tested from concentrations of 0-3000 mg/dL
because they had a wider range of detection than the Siemens Multistix. Comparison between
the two graphs show that they have differing RGB intensities depending on the concentration
and thus the equations obtained by these graphs cannot be used interchangeably. The RGB
graph for the Precision Strips show that the blue intensity is almost flat. This makes the red and
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green equation that will be obtained by the graph far more important when creating the
algorithm.

Figure 5.1-3: RGB Graph for pH for Siemens Multistix

pH is an indicator of how acidic or alkaline a patient’s urine is and can predict the
likelihood of kidney stones in a patient. 22 The average pH level of urine is 6, but the level can
fluctuate depending on a patient’s diet or health condition. 23 If a patient’s urine is acidic, less
22

Healthline. “Urine PH Level Test: Purpose, Procedure & Side Effects.” Healthline, Healthline Media,
www.healthline.com/health/urine-ph.
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than 6, this can indicate certain conditions such as kidney stones, dehydration, diabetes, and
starvation. If a patient’s urine is alkaline, higher than 6, then it is indicative of conditions such
as kidney failure, kidney tubular acidosis, or urinary tract infection.24 pH levels in urine can
range anywhere from 5.1-8. 25 The tests were conducted for pH used pH levels of 5-9.
However, Siemens Multistix failed to have a significant color change and tests above a pH of 9
were conducted using the Multistix.
Figure 5.1-3, shows the RGB graph of pH as the pH level increases. Of the graphs
constructed, the pH showed the most difference from the theoretical change in color described
on the Siemens Multistix 10 SG Reagent Strips. The test ranges described on the label were
listed for pH levels from 5 to 9. However, our tests showed a significant change only occurring
when the pH levels were above 9. This would become very important when calibrating the
device and later creating the algorithm for the web application.

Figure 5.1-4: RGB Graph for pH for Precision Strips

Healthline. “Urine PH Level Test: Purpose, Procedure & Side Effects.” Healthline, Healthline Media,
www.healthline.com/health/urine-ph.
25
RENCEUS. “Urine PH.” Urine PH, RNCEUS, www.rnceus.com/ua/uaph.html.
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Figure 5.1-4 displays the RGB graph for the Precision Strips with differing
concentrations of pH. Like the Siemens Multistix, these tests were conducted from pH levels of
5 to 9. As seen on the bottle of the Precision Strips, there is a drastic change in pH from around
6 to 8 pH. This differs from the Siemens Multistix, which only has a drastic change after the
pH reaches a level of 9. From our tests, Precision Strips display a higher sensitivity when the
pH level changes.

Figure 5.1-5: RGB Graph for Nitrite for Siemens Multistix
While nitrate can be found in urine, nitrite should not be present in a patient’s urine at
all.26 Nitrate in urine can be transformed into nitrite if there is bacteria present, which can occur
if a patient has urinary tract infection.27 Because nitrite should not be found in a patient’s urine
at all, we conducted nitrite testing for very low concentrations of nitrite in DI water.
The RGB graph constructed for the different concentrations of nitrite, which can be found in
26

Healthline. “Nitrites in Urine: Causes, Symptoms, and Treatments.” Healthline, Healthline Media,
www.healthline.com/health/nitrites-in-urine#1.
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Figure 5.1-5. The intensity of the red, green, and blue fluctuate the same way for each color as
the concentration of nitrite increases in all of the cases that were tested. The tests were
conducted for concentrations of nitrite from 0-0.1 mg/dL because nitrite should not be found in
urine at all, so we hoped the strips would have significant changes in color with small increases
in nitrite concentration. However, the nitrite strip results dip down back near the original RGB
intensities seen at 0 mg/dL. As of right now, we have determined that this information can be
used to predicted the presence of nitrite in urine, but further tests must be conducted in order to
see if it is possible to obtain an algorithm that will be able to predict the concentration of nitrite
in a patient’s urine.

Figure 5.1-6: RGB Graph for Urobilinogen for Siemens Multistix
Urobilinogen is a compound that can be found in trace amounts in urine and is typically
observed to find liver problems.28 The clinically acceptable concentration of urobilinogen in a
patient’s urine is considered to be <1 mg/dL, but it can range anywhere from 0-8 mg/dL, which

28

MedlinePlus. “Urobilinogen in Urine: MedlinePlus Lab Test Information.” MedlinePlus, U.S. National Library
of Medicine, 22 Sept. 2017, medlineplus.gov/labtests/urobilinogeninurine.html.
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is the range we tested for in our experiments.29 Too little urobilinogen, is indicative of liver
blockage or issues with liver function while high concentrations of urobilinogen indicate health
conditions like hepatitis, cirrhosis, or liver damage.30
Figure 5.1-6 displays the plot of the RGB intensity as the levels of urobilinogen in urine
increase as found through our experiments. As seen in the graph, the intensity values for the
blue and green color of the strip are more drastic than that of the red color, which means that
those values will be far more valuable in constructing the algorithm needed for the app. The
changes in RGB are more significant below the 4 mg/dL concentration of urobilinogen, so the
RGB values will be helpful in predicting the concentration of urobilinogen in a patient’s urine
as it increases.

29

Marchione, Victor. “What Does Urobilinogen in Urine Mean? Causes, Symptoms, Tests, and Treatment.” Bel
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Figure 5.1-7: RGB Graph for hCG
hCG is a hormone present in urine when a woman becomes pregnant. The Wondfo
strips can only detect after two weeks of a woman’s pregnancy, but we tested a range of
0-6400 mIU/mL to determine if we could obtain equations to predict a patient’s stage of
pregnancy. Because it is critical to determine a patient’s pregnancy as soon as possible, we
focused on testing from ranges of 0-1600 mIU/mL, which is the normal concentration of hCG
during 0-3 weeks of pregnancy.31
Figure 5.1-7 displays the RGB graph that were obtained for hCG. Unlike the Siemens
Multistix 10 SG Reagent strips, the Wondfo strips that were used to detect hCG only confirm
the presence of the biomarker rather than giving an estimate of the concentration of the
biomarker as well as confirming the presence or absence of it in urine. As a result, the RGB
graph for hCG lacks the curves seen in the other RGB graphs for the other parameters that used

31
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Siemens Multistix 10 SG Reagent strips for testing. Instead there is a sharp change in slope
after the 1600 mIU/mL concentration where the graph has a very shallow slope, indicating a
positive pregnancy. As a result, the information taken from this graph would only allow the
algorithm to confirm that a patient is pregnant rather than predicting how many months
pregnant a patient is.

Figure 5.1-8: RGB Graph for Albumin

Albumin is a protein that can be found in urine and can be observed to determine if a
patient has kidney disease.32 The clinically acceptable range of albumin in urine is 30 mg/dL
and a patient is considered to have albuminuria if the concentration of albumin in urine is
greater than 300 mg/dL.33
Figure 5.1-8 above shows the RGB graph for the urine albumin strips that
National Institute of Diabetes and Digestive and Kidney Diseases. “Albuminuria: Albumin in the Urine.”
National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human
Services, 1 Oct. 2016
33
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National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human
Services, 1 Oct. 2016
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manufactured in lab. The concentrations that were tested ranged from 0-2000 mg/dL, which is
far above the normal 300 mg/dL that is found in patients with albuminuria. This is because we
wanted to determine if the strips constructed would be able to detect albuminuria in a patient.
As seen in the graph, our strips can successfully determine if a patient has high enough levels
of albumin in their urine to indicate albuminuria, which is shown to the left of the black line on
the graph. Our tests also show that the strips are able to determine the concentration of albumin
in a patient’s urine from concentrations of 160-300 mg/dL, alerting patients to take steps in
preventing albuminuria from occurring.

Figure 5.1-9: RGB Graph for pH for Siemens Multistix in Varying Glucose
We also conducted tests with multiple parameters to determine whether the presence of
additional biomarkers would affect the biomarker being observed. Figure 5.1-9 above displays
the results of one of these combination parameter tests where we observe the RGB of the pH
reagent pad of the Siemens Multistix. Because only glucose is varied, the expected graph
should have a flat line because pH is unchanging. As Figure 5.1-9 shows, the RGB intensity
does vary slightly as glucose is increased, particularly between glucose concentrations of
0-1000 mg/dL.
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Figure 5.1-10: RGB Graph for pH for Precision Strips for Varying Glucose
We also constructed a similar RGB graph for the Cynmar Precision Strips that observed
the RGB of pH as the concentration of glucose was increased. Figure 5.1-10 displays the result,
showing how the RGB intensity of pH changes as glucose is added to the sample. Compared to
the Siemens Multistix, the Precision Strips are much more sensitive to change when additional
parameters are present, suggesting that Siemens Multistix may be more accurate in monitoring
a patient’s health because the color change is not as drastic even when multiple biomarkers are
present in the sample.
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Figure 5.1-11: RGB Graph for Glucose for Siemens Multistix with Constant pH of 7
During these same combination tests, we observed the RGB as we increased glucose at
a constant pH of 7. Although the average pH level of a healthy patient is 6, we expected that
the glucose graphs that were to be obtained by both the Siemens Multistix and the Cynmar
Precision Strips to be close in trend to the original graphs we obtained in isolation tests.
The RGB graph obtained for the glucose isolation test for Siemens Multistix, seen in
Figure 5.1-1, displays trends that are similar to the ones observed in Figure 5.1-11 for
combination tests of varying glucose and constant pH using Siemens Multistix. However, the
red intensity for the combination RGB graph is far more linear than the one seen in
combination testing. Further testing is required to acquire a more accurate graph and determine
how much variance occurs when multiple biomarkers are present.
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Figure 5.1-12: RGB Graph for Glucose for Precision Strips with Constant pH of 7
The results for the Cynmar Precision Strips for combination testing of varying glucose
and constant pH 7 can be observe in Figure 5.1-12 above. Like the Siemens Multistix, the
graph has differences compared to the one found in isolation testing, which can be seen in
Figure 5.1-2. However, the variance between the combination graph and the isolation graph for
Cynmar Precision Strips have greater differences in the changing RGB intensities, which
means the Precision Strips are much more sensitive when multiple parameters are present.
While the blue intensity was previously observed to be nearly flat in the isolation graph even as
the concentration of glucose increased, the combination graph above shows a drastic increase
of blue as glucose increases. Further testing is required to determine how much variance occurs
when multiple parameters are present and how to take these different factors into account when
creating the algorithm.
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Figure 5.1-13: RGB Graph for pH for Multistix in Artificial Urine
Our final tests were conducted with solutions with the observed biomarker dissolved in
artificial urine. Previously, the tests were done using samples dissolved in DI water, but
artificial urine was used to obtain results that would be closer to those obtained using real urine
samples.
Figure 5.1-13 above displays the RGB graph of pH for Multistix in artificial urine. The
graph follows a similar trend seen in Figure 5.1-3 in the pH isolation test for Siemens
Multistix. However, a drastic change from pH levels 7 to 9 is present in the artificial urine test
and is not present in the isolation test using DI water. Previously, it was determined that the pH
sensitive for Siemens Multistix was not good because of the lack of change, but there is a
substantial difference that should allow the algorithm to determine pH change as the patient’s
urine becomes more alkaline. Should these tests be repeated in the future, artificial urine
should be used rather than DI water because it results in changes that are closer to those found
on the bottle.
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Figure 5.1-14: RGB Graph for pH for Precision Strips in Artificial Urine
The last RGB graph, seen in Figure 5.1-14 above, displays the pH graph for the
Precision Strips in artificial urine. The trends seen in this graph and the isolation graph for the
same test in DI water, which can be observed in Figure 5.1-4, are similar but the curve for the
blue intensity is seen to be smoother. However, the drastic change in color from pH levels of 7
to 9 are similar to those found in the DI water isolation test. While the graphs follow the same
trends overall, it is best to do these tests using artificial urine to obtain results that will be
closer to those that will be found using patient’s urine.

6

Summary

6.1

Project Goals
The goal of the project is to design a case for an imaging device in order to take images

for urinalysis strips. The case should be able to provide consistent lighting so that the web
application paired with the device can accurately analyze the results of the urinalysis tests.
Because the device needs to be portable, the device should be designed to be compact,
relatively light, and be made out of a durable material. It is also important that the lighting’s
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power source come from batteries and be rechargeable so it can be used without having to be
plugged into another power source.
The algorithm that the web application used to analyze the images of the urinalysis tests
taken by the device needed to be calibrated using known concentrations of the same
biomarkers being tested. Using the images of the concentrations used for the standard, the
RGB values were graphed and an equation was found for each biomarker. These equations
were used to create the algorithm to analyze urinalysis results that the complementary
computer engineering team will be working on.
6.2

Work Done
The bioengineering team worked on preparing different concentrations of all of the

biomarkers for testing. Three images were taken for each concentration per parameter and the
images were cropped to create RGB values. These graphs were given to the computer
engineering team to determine the RGB equations for the algorithm needed for the web
application. Additionally, they also constructed their own albumin strips in the lab as well as
built an imaging device compatible with a Samsung tablet for WHP.
The computer engineering team worked on calibration by gathering the RGB equations
to create the algorithm the web application plans on using in order to give an accurate reading
of the urinalysis tests. The computer engineering team also worked on the design layout of the
application as well as the different functionalities that would be required for the app such as
cropping, image uploading, and image capturing.
6.3

Future Work
While the albumin strips made could successfully detect albumin in urine and also

differentiate between microalbumin and macroalbumin, there could be improvements in in
manufacturing them in order to reduce the cost. The printer used to print the reagent onto the
strip could print out the small amount of reagent needed, but it was too time-consuming and
also used up many liquid cartridges in the process. As a result, the final albumin strips were
handmade, but the uniform distribution of the reagent cannot be confirmed. In the future, the
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strips should be manufactured so that the reagent is spread out evenly on the paper and use a
printer that can dispense large amounts of liquid so that the reagent pads can be cut into the
desired size for the strips.
Future work on the project should also include producing strips that detect other
biomarkers in addition to the ones that were used in this project. The Cynmar Precision strips
used by WHP and other similar commercial strips can only detect biomarkers like glucose, pH,
and ketones. The inclusion of a variety of other biomarkers would allow the detection of other
diseases and greatly improve health monitoring.
Most of the tests conducted were done using DI water. However, later tests showed that
artificial urine yielded results that would be closer to those that would be found if real urine
were used. In the future, the parameter testing should be done using artificial urine to better
recapitulate real urinalysis tests.
6.4

Discussion
The device hardware overall satisfies the customers needs. The weight and the

dimensions of the device allow it to be easily transported and therefore, comply with customer
constraints. The acrylic material of the device is also optimal because of its durability. The
strip holder in the final device is compatible with the Cynmar Precision Strips used by WHP.
The device is also compatible with the Samsung tablet that WHP uses for capturing their
images. The black acrylic box successfully keeps out ambient light that could affect images
used in the app, allowing for more accurate results. The device also has LEDs powered by
lithium batteries, which allow clinicians to use the device without the need for an external
power source. The lithium batteries also have a long battery life so that the device can be used
for a long time without needing to be charged or having its battery replaced. .
Our team has successfully been able to test all desired parameters individually in a
timely manner. Our isolation tests yielded results to create an algorithm that could determine
the concentrations of different samples for all six of our parameters: glucose, pH, nitrite,
urobilinogen, hCG, and albumin. We were also able to perform combination tests with glucose
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and pH to determine how the results varied when multiple parameters were present in the
sample. We determined that the parameters could affect the results and that these should be
taken into account when creating the algorithm. In addition, we were able to observe the same
tests using artificial urine in order to determine whether the results obtained were more
accurate than the results obtained from the tests conducted with DI water. While the trends
were similar, the ones observed with artificial urine yielded results that were closer to those
seen on the labels of the urinalysis test strips.
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